Apyx Medical Valuation Multiples

Apyx Medical Overview

About Apyx Medical

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Founded

1982

HQ

Employees

220

Website

apyxmedical.com

Sectors

Medical DevicesHealthTechDeepTech

Financials (LTM)

Revenue: $54M

EBITDA: ($4M)

EV

$174M

Valuation Multiples

Multiples.vc

Start free trial

Apyx Medical Financials

Apyx Medical reported last 12-month revenue of $54M and negative EBITDA of ($4M).

In the same LTM period, Apyx Medical generated $34M in gross profit, ($4M) in EBITDA losses, and had net loss of ($12M).

Apyx Medical P&L

In the most recent fiscal year, Apyx Medical reported revenue of $53M and EBITDA of ($4M).

Apyx Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX

Apyx Medical Stock Performance

Apyx Medical has current market cap of $166M, and enterprise value of $174M.

Apyx Medical's stock price is $3.98.

Apyx Medical Valuation Multiples

Apyx Medical trades at 3.2x EV/Revenue multiple, and (38.8x) EV/EBITDA.

Apyx Medical Financial Valuation Multiples

As of April 20, 2026, Apyx Medical has market cap of $166M and EV of $174M.

Equity research analysts estimate Apyx Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Apyx Medical has a P/E ratio of (13.8x).

Apyx Medical Margins & Growth Rates

Apyx Medical's revenue in the last 12 month grew by 10%.

Apyx Medical's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.

Apyx Medical's rule of 40 is (1%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Apyx Medical's rule of X is 13% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Apyx Medical Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Apyx Medical M&A Activity

Apyx Medical acquired XXX companies to date.

Last acquisition by Apyx Medical was on XXXXXXXX, XXXXX. Apyx Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Apyx Medical Investment Activity

Apyx Medical invested in XXX companies to date.

Apyx Medical made its latest investment on XXXXXXXX, XXXXX. Apyx Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).